How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Polypeptide Solid Phase Synthesis Carrier Market
- By Carrier Material Type: Polystyrene Resin, Polyethylene Glycol (PEG) Resin, Polyacrylamide Resin, Polyvinyl Alcohol (PVA) Resin, Silica-based Resin
- By Functional Group Type: Chloromethyl, Hydroxymethyl, Aminomethyl, Carboxyl, Wang Resin
- By Loading Capacity: Low Loading (≤0.5 mmol/g), Medium Loading (0.5-1.0 mmol/g), High Loading (>1.0 mmol/g)
- By Application: Peptide Synthesis, Oligonucleotide Synthesis, Combinatorial Chemistry, Drug Discovery and Development, Bioconjugation
- By End-User: Pharmaceutical Companies, Biotechnology Firms, Academic and Research Institutes, Contract Research Organizations (CROs)
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Polystyrene Resin leads By Carrier Material Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 14 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 296 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.181 →
- 12 Company Profiles 14 players: SWOT & benchmarking p.189 →
Full report · locked preview
Everything inside the Polypeptide Solid Phase Synthesis Carrier Market report
A complete, evidence-based study - 12 chapters and 124 sections covering market size, segmentation across 5 axes, regional analysis and 14 company profiles, forecast to 2033.
Segmentation covered
Carrier Material Type 5
Functional Group Type 5
Loading Capacity 3
Application 5
End-User 4
Companies profiled
Merck KGaA (MilliporeSigma)
Thermo Fisher Scientific
Bachem Holding AG
CEM Corporation
Iris Biotech GmbH
GL Biochem (Shanghai) Ltd.
Peptide Synthetics Ltd.
CSBio Co. Ltd.
AAPPTec Inc.
Ontores Biotechnologies Ltd.
PolyPeptide Group
Biosynth Carbosynth
+2 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
14 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Merck KGaA (MilliporeSigma)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Thermo Fisher Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Bachem Holding AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →CEM Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Iris Biotech GmbH
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →GL Biochem (Shanghai) Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Peptide Synthetics Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →CSBio Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →AAPPTec Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Ontores Biotechnologies Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →PolyPeptide Group
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Biosynth Carbosynth
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →CPC Scientific Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Synpeptide Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$2,464M by 2033 · 3.3% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Polystyrene Resin50.7
- Polyethylene Glycol (PEG) Resin15.4
- Polyacrylamide Resin11.9
- Polyvinyl Alcohol (PVA) Resin7.0
- Silica-based Resin15.0
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$628.3M → $791.7M · 2.9%
Europe$437.9M → $584.2M · 3.7%
Asia Pacific$399.9M → $496.7M · 2.7%
Latin America$247.5M → $328.4M · 3.6%
Middle East and Africa$190.4M → $258.6M · 3.9%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →3.222026
3.252027
3.262028
3.252029
3.272030
3.282031
3.302032
3.302033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Merck KGaA (MilliporeSigma)22.1
- Thermo Fisher Scientific15.3
- Bachem Holding AG9.5
- CEM Corporation6.5
- Iris Biotech GmbH10.4
- GL Biochem (Shanghai) Ltd.8.2
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Carrier Material Type10.5%
Functional Group Type24.4%
Loading Capacity15.9%
Application25.3%
End-User23.9%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.2
- Europe23.8
- Asia Pacific20.2
- Latin America13.4
- Middle East and Africa10.5
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Merck KGaA (MilliporeSigma) | 93 | 82 | 74 | 90 | 89 | 78 | 84 |
| Thermo Fisher Scientific | 93 | 90 | 84 | 80 | 86 | 91 | 87 |
| Bachem Holding AG | 66 | 69 | 85 | 80 | 74 | 62 | 73 |
| CEM Corporation | 61 | 67 | 63 | 65 | 74 | 62 | 65 |
| Iris Biotech GmbH | 65 | 72 | 69 | 69 | 67 | 77 | 70 |
| GL Biochem (Shanghai) Ltd. | 46 | 55 | 46 | 68 | 71 | 60 | 58 |
| Peptide Synthetics Ltd. | 51 | 48 | 52 | 42 | 63 | 65 | 54 |
| CSBio Co. Ltd. | 48 | 51 | 46 | 55 | 44 | 47 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Merck KGaA (MilliporeSigma)
- Thermo Fisher Scientific
- Bachem Holding AG
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Merck KGaA (MilliporeSigma) | ✓ | ✓ | ◐ | ◐ | ✓ | ✓ |
| Thermo Fisher Scientific | ✓ | ✓ | ✓ | ◐ | ✓ | ✓ |
| Bachem Holding AG | ✓ | ◐ | ✓ | ✓ | ◐ | ◐ |
| CEM Corporation | − | ◐ | ◐ | ◐ | ✓ | ◐ |
| Iris Biotech GmbH | − | ✓ | ✓ | ◐ | ✓ | ✓ |
| GL Biochem (Shanghai) Ltd. | − | − | ◐ | ✓ | ✓ | ◐ |
| Peptide Synthetics Ltd. | − | ◐ | − | − | ◐ | ◐ |
| CSBio Co. Ltd. | − | − | ◐ | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Thermo Fisher Scientific87
2Merck KGaA (MilliporeSigma)84
3Bachem Holding AG73
4Iris Biotech GmbH70
5CEM Corporation65
6GL Biochem (Shanghai) Ltd.58
7Peptide Synthetics Ltd.54
8CSBio Co. Ltd.49
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Merck KGaA (MilliporeSigma)Thermo Fisher Scientific
Challenger2
Strong scale, closing on the leaders.
Bachem Holding AGIris Biotech GmbH
Contender2
Focused players with pockets of strength.
CEM CorporationGL Biochem (Shanghai) Ltd.
Niche2
Specialists in a single segment or region.
Peptide Synthetics Ltd.CSBio Co. Ltd.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Carrier Material Type in North America, then scale across Polypeptide Solid Phase Synthesis Carrier Market — a $531M beachhead inside a $9.36B market.
Beachhead (SOM)$531Mobtainable near-term
Serviceable (SAM)$3.41Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Polystyrene Resin
Best fit — highest urgency & budget in Carrier Material Type.
Economic buyer81 fit
Polyethylene Glycol (PEG) Resin
Strong fit — clear ROI and a fast path to value.
End user70 fit
Polyacrylamide Resin
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Carrier Material Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Functional Group Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Loading Capacity
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales47%
Partner / channel26%
Digital / self-serve20%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Carrier Material Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Polypeptide Solid Phase Synthesis Carrier Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified43%
Sales qualified21%
Evaluation14%
Closed-won7%
$20.8KCAC
$103KLTV
5.0:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Polypeptide Solid Phase Synthesis Carrier Market is a durable-growth opportunity — $9.41B by 2033, compounding at 7.0%.
TAM · 2025$5.49Btoday
TAM · 2033$9.41Bforecast
CAGR7.0%2027–2033
Cumulative$65.7Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$9.41BTotal addressable market
SAM$3.64BServiceable available market
SOM$661MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →7.0% CAGR
Demand compounds through 2033, outpacing GDP across Carrier Material Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Carrier Material Type moving from early to mainstream — durable secular demand.
Consolidation upside
14+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$9.41BLarge & growingTAM by 2033 at 7.0% CAGR
$3.64BServiceable nowreachable with today’s model
$661MBeachhead winobtainable near-term share
14+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$7.34BBear4.5% CAGR
$9.41BBase7.0% CAGR
$12.1BBull9.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Functional Group Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Polypeptide Solid Phase Synthesis Carrier Market — a $8.62B market by 2033. Plan: grow share from 9.0% to 18.2%.
Market size · 2033$8.62Btotal addressable
Market CAGR11.7%2027–2033
Target share18.2%from 9.0% today
Revenue ambition$1.57Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.0% | 18.2% | Behind |
| Revenue | $731M | $1.57B | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 29.0% | 39.6% | Behind |
| Customer retention | 86.8% | 94.5% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Carrier Material Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Functional Group Type capability
A defensible second engine — invest in Functional Group Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Carrier Material Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Functional Group Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $165M capacity & capability investment
- Greenlight bolt-on M&A in Functional Group Type
- Authorise North America expansion plan
- Fund R&D program for Carrier Material Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossAhead
- Input-cost & supply riskOn track
- Regulatory / policy changeOn track
- Execution & talentBehind
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Polypeptide Solid Phase Synthesis Carrier Market conversation — a $3.74B market you can size, segment and defend in minutes.
Market size · 2033$3.74Btotal opportunity
Growth6.7%CAGR to 2033
Addressable buyers1,706+accounts in scope
Typical ROI4.6×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Carrier Material Type
Goal Grow share in Carrier Material Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.6×return on cost, year one
< 3 mopayback period
$85K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
14+players profiled in this market
Coverage includes
Merck KGaA (MilliporeSigma)Thermo Fisher ScientificBachem Holding AGCEM CorporationIris Biotech GmbHGL Biochem (Shanghai) Ltd.Peptide Synthetics Ltd.CSBio Co. Ltd.+6 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Polypeptide Solid Phase Synthesis Carrier Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Polypeptide Solid Phase Synthesis Carrier Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Polypeptide Drug Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportPolypeptide Anti-aging Agent Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportPolyoxymethylene (POM) Resins for Medical Instruments Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportPolymyxin E Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportPolymyxin B Sulfate Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportPoly-Myalgia Rheumatica Treatment Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportPolymer Stent Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportPolymer Stent Graft Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportPolymer Prefilled Syringe Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportPolymer Pre-fillable Syringe Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportPolymer Material Prefilled Syringes Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportPolymer Material Large Diameter Artificial Blood Vessel Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.